Intralesional chemotherapy for Kaposi's sarcoma

L. Brambilla, V. Boneschi, G. Beretta, A. F. Finzi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Over a period of 36 months we treated 12 patients with skin localizations of Kaposi's sarcoma with intralesional chemotherapy. Local administration of vincristine (usual dose 0.1 mg per site) or bleomycin appeared to be very effective: in 93 injected nodules we obtained 74 complete and 19 partial regressions. No significant local or systemic toxicity has so far been observed.

Original languageEnglish
Pages (from-to)150-155
Number of pages6
JournalDermatologica
Volume169
Issue number3
Publication statusPublished - 1984

Fingerprint

Kaposi's Sarcoma
Bleomycin
Vincristine
Drug Therapy
Skin

ASJC Scopus subject areas

  • Dermatology

Cite this

Brambilla, L., Boneschi, V., Beretta, G., & Finzi, A. F. (1984). Intralesional chemotherapy for Kaposi's sarcoma. Dermatologica, 169(3), 150-155.

Intralesional chemotherapy for Kaposi's sarcoma. / Brambilla, L.; Boneschi, V.; Beretta, G.; Finzi, A. F.

In: Dermatologica, Vol. 169, No. 3, 1984, p. 150-155.

Research output: Contribution to journalArticle

Brambilla, L, Boneschi, V, Beretta, G & Finzi, AF 1984, 'Intralesional chemotherapy for Kaposi's sarcoma', Dermatologica, vol. 169, no. 3, pp. 150-155.
Brambilla L, Boneschi V, Beretta G, Finzi AF. Intralesional chemotherapy for Kaposi's sarcoma. Dermatologica. 1984;169(3):150-155.
Brambilla, L. ; Boneschi, V. ; Beretta, G. ; Finzi, A. F. / Intralesional chemotherapy for Kaposi's sarcoma. In: Dermatologica. 1984 ; Vol. 169, No. 3. pp. 150-155.
@article{db189109e203411188ec3a4e5ecca87a,
title = "Intralesional chemotherapy for Kaposi's sarcoma",
abstract = "Over a period of 36 months we treated 12 patients with skin localizations of Kaposi's sarcoma with intralesional chemotherapy. Local administration of vincristine (usual dose 0.1 mg per site) or bleomycin appeared to be very effective: in 93 injected nodules we obtained 74 complete and 19 partial regressions. No significant local or systemic toxicity has so far been observed.",
author = "L. Brambilla and V. Boneschi and G. Beretta and Finzi, {A. F.}",
year = "1984",
language = "English",
volume = "169",
pages = "150--155",
journal = "Dermatologica",
issn = "0011-9075",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Intralesional chemotherapy for Kaposi's sarcoma

AU - Brambilla, L.

AU - Boneschi, V.

AU - Beretta, G.

AU - Finzi, A. F.

PY - 1984

Y1 - 1984

N2 - Over a period of 36 months we treated 12 patients with skin localizations of Kaposi's sarcoma with intralesional chemotherapy. Local administration of vincristine (usual dose 0.1 mg per site) or bleomycin appeared to be very effective: in 93 injected nodules we obtained 74 complete and 19 partial regressions. No significant local or systemic toxicity has so far been observed.

AB - Over a period of 36 months we treated 12 patients with skin localizations of Kaposi's sarcoma with intralesional chemotherapy. Local administration of vincristine (usual dose 0.1 mg per site) or bleomycin appeared to be very effective: in 93 injected nodules we obtained 74 complete and 19 partial regressions. No significant local or systemic toxicity has so far been observed.

UR - http://www.scopus.com/inward/record.url?scp=0021179076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021179076&partnerID=8YFLogxK

M3 - Article

VL - 169

SP - 150

EP - 155

JO - Dermatologica

JF - Dermatologica

SN - 0011-9075

IS - 3

ER -